pasticceria Critica lungimiranza ym155 clinical trial Cipiglio gruppo musicale barbecue
YM155 affects the expression of XIAP as well as survivin in pancreatic... | Download Scientific Diagram
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
JCM | Free Full-Text | Epigenetic Changes at the Birc5 Promoter Induced by YM155 in Synovial Sarcoma | HTML
IJMS | Free Full-Text | Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells | HTML
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction - ScienceDirect
Summary of clinical trials using YM155 in cancer. | Download Scientific Diagram
Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155) - RSC Medicinal Chemistry (RSC Publishing)
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv
A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma - Kudchadkar - 2015 - Cancer Medicine - Wiley Online Library
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines | bioRxiv
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
Cancers | Free Full-Text | Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer - Annals of Oncology
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports
Summary of clinical trials using YM155 in cancer. | Download Scientific Diagram
Changes in survivin expression in serial biopsied tumor pre- and... | Download Scientific Diagram
YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice | Oncotarget
Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK | Scientific Reports